TITLE

Increase in the Prevalence of the Newly Discovered Pneumococcal Serotype 6C in the Nasopharynx after Introduction of Pneumococcal Conjugate Vaccine

AUTHOR(S)
Nahm, Moon H.; Jisheng Lin; Finkelstein, Jonathan A.; Pelton, Stephen I.
PUB. DATE
February 2009
SOURCE
Journal of Infectious Diseases;2/1/2009, Vol. 198 Issue 3, p320
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Because pneumococcal serotype 6C was previously not distinguished from serotype 6A, the impact of the 7-valent pneumococcal conjugate vaccine (PCV7) on the carriage of serotype 6C is unknown. Methods. The nasopharyngeal (NP) prevalence of the 6C serotype was determined using 1326 pneumococcal isolates collected from 7 cohorts of Massachusetts children between 1994 and 2007. Initially, the isolates were serotyped using the quellung reaction; subsequently, stored specimens of all putative 6A isolates were tested for 6C using monoclonal antibodies. The opsonophagocytic and antibiotic susceptibilities of the isolates were determined. Results. The prevalence of 6A was 9.6% (33/343) before 2001, 8.0% (18/226) in 2004, and 2.9% (12/416) in 2007. In contrast, the prevalence of 6C was 0.6% (2/343) before 2001, 2.2% (5/226) in 2004, and 8.7% (36/416) in 2007 (P < .001 for 2/343 vs. 36/416). 6C isolates from 2007 were more susceptible to antibiotics than were 6A isolates. PCV7 induced a low ability to opsonize different isolates of 6C. Conclusions. Among NP isolates, the prevalence of 6C isolates has increased and the prevalence of 6A isolates has decreased since the introduction of PCV7 in Massachusetts in 2000. The observed increase in serotype 6C prevalence may be explained by the induction by PCV7 of low amounts of functional anti-6C antibody, compared with anti-6A and anti-6B antibodies.
ACCESSION #
36327984

 

Related Articles

  • Immunotoxins containing Pseudomonas exotoxin A: a short history. Pastan, Ira // Cancer Immunology, Immunotherapy;May2003, Vol. 52 Issue 5, p338 

    Focuses on the history of research on immunotoxins containing Pseudomonas exotoxin. Identification of a large variety of monoclonal antibodies that bind to antigens on cancer cells; Function of Pseudomonas exotoxin; Phases of the development of immunotoxins.

  • CHARACTERISTICS OF TOLERANCE IN MOUSE HEART ALLOGRAFTS AFTER TREATMENT WITH MONOCLONAL ANTIBODIES AND IMMUNOCONJUGATES.  // Immunology & Cell Biology;Dec1993, Vol. 71 Issue 6, special section pS6 

    The article presents a study comparing the effects of anti-CD8, and anti-CD4 mAb, and immunoconjugates of these mAb, on the survival of cardiac allografts and examined the changes in T cell reactivity in mice rendered tolerant by these treatments. Both anti-CD4 and CD8 treatments could...

  • Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate. Neumeister, P.; Eibl, M.; Zinke-Cerwenka, W.; Scarpatetti, M.; Sill, H.; Linkesch, W. // Annals of Hematology;Feb2001, Vol. 80 Issue 2, p119 

    Monoclonal antibodies recognizing hematopoietic antigens are increasingly being used to target therapy directly at leukemic cells, with the aim of achieving sustained remission with little systemic toxicity. Administration of anti-CD33 calicheamicin immunoconjugate is commonly regarded as being...

  • Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. Sawada-Hirai, Ritsuko; Jiang, Ivy; Fei Wang; Shu Man Sun; Nedellec, Rebecca; Ruther, Paul; Alvarez, Alejandro; Millis, Diane; Morrow, Phillip R.; Kang, Angray S. // Journal of Immune Based Therapies & Vaccines;2004, Vol. 2, p5 

    Background: Potent anthrax toxin neutralizing human monoclonal antibodies were generated from peripheral blood lymphocytes obtained from Anthrax Vaccine Adsorbed (AVA) immune donors. The anti-anthrax toxin human monoclonal antibodies were evaluated for neutralization of anthrax lethal toxin in...

  • Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug. Cheng, T L; Roffler, S R // British Journal of Cancer;3/15/99, Vol. 79 Issue 9/10, p1378 

    RHI-βG-PEG, formed by linking poly(ethylene glycol)-modified β-glucuronidase to Mab RH1, was employed to examine bystander killing of antigen-negative N1S1 rat hepatoma cells by activation of a glucuronide prodrug (BHAMG) of p-hydroxyaniline mustard (pHAM) at antigen-positive AS-30D rat...

  • Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies. Chiarella, Pieranna // Recent Patents on Anti-Cancer Drug Discovery;May2011, Vol. 6 Issue 2, p258 

    Since the advent of hybridoma technology 35 years ago, research on monoclonal antibodies has developed enormously. Monoclonal antibodies of mouse origin were the first to be produced and continue to be the most popular affinity reagents for investigating the proteome of all organisms. For their...

  • A Divalent Recombinant Immunotoxin Formed by a Disulfide Bond between the Extension Peptide Chains. Ji Hae Park; Hye Won Kwon; Hee Kyoung Chung; Ik-Hwan Kim; Kwangseog Ahn; Eui-Ju Choi; Pastan, Ira; MuHyeon Choe // Molecules & Cells (Springer Science & Business Media B.V.);2001, Vol. 12 Issue 3, p398 

    Recombinant immunotoxin for the treatment of cancer was made by connecting toxins to 'carcinoma-specific' antibodies that selectively bind to cancer cells, then kills them without harming the normal cells. The divalent recombinant immunotoxin. [B3(Fab)-ext-PE38]2, is a derivative of...

  • Specific antibody deficiency in children with chronic wet cough. Lim, Michael Teik Chung; Jeyarajah, Kayathrie; Jones, Philippa; Pandya, Hitesh; Doffinger, Rainer; Kumararatne, Dinakantha; Browning, Michael J.; Gaillard, Erol A. // Archives of Disease in Childhood;May2012, Vol. 97 Issue 5, p478 

    The prevalence and clinical significance of specific polysaccharide antibody deficiency (SAD) in children are poorly understood. The authors sought to determine the prevalence of SAD in children with chronic wet cough, through a retrospective study of all children with chronic wet cough...

  • Autoimmune homeostasis in vaccination -- "Pneumo 23" vaccine. Matveichev, A. V.; Mokhonova, E. V.; Nikitina, Z. I.; Koptelova, V. N.; Korshunova, E. A. // Vestnik Sankt-Peterburgskogo universiteta, Seriia 7: Geologia, G;2013, Issue 4, p76 

    This article evaluates autoimmune homeostasis change upon vaccination with "Pneumo 23" vaccine, used for army platoon protection. It was revealed that vaccination induces the rise of IgM á´» IgG anti-cardiolipin antibodies from day 20 after vaccine introduction to day 319,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics